Latest Breaking News On - Medical technologies industry - Page 1 : comparemela.com

United States - Healthcare - FDA Finalizes New Rule For Lab-Developed Tests

United States - Healthcare - FDA Finalizes New Rule For Lab-Developed Tests
mondaq.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mondaq.com Daily Mail and Mail on Sunday newspapers.

Audreym adamsColeenw hillVickig nortonDrug administrationLife sciencesFederal foodDevice amendmentsBeginning mayBeginning novemberMedical technologies industry

USPTO Proposes Significant Fee Increases Impacting Patent Prosecution Practices - Patent

The USPTO is soliciting comments regarding its proposed fee increases for fiscal year 2025. Written comments must be received on or before June 3, 2024, to ensure consideration.

United statesHeidi lunasinVickig nortonBryanc smithHuman servicesProperty practice groupLife sciencesDepartment of healthConsideration programFederal registerNon provisional applicationsContinuation in part applicationsEarliest priorityUndiscounted non provisionalApplicant provided itemsFinal consideration program

FTC Supports Marching In On Patent Rights As A Mechanism To Control Drug Prices - Patent

The Federal Trade Commission (FTC) has announced its support of the federal government's use of "march-in rights" as a mechanism to control the price of pharmaceuticals.

United statesSarah olaughlin kulikSeanp mcconnellLife sciencesInstitute of standardsCompetition groupFederal trade commissionInteragency guidanceBayh dole actPresident joe bidenExecutive orderPromoting competitionSaraho laughlin kulikMedical technologies industryFtc supports marching in on patent rights asa mechanism to control drug pricesAntitrust competition law

White House Announces Framework For Use Of March-In Rights Under The Bayh-Dole Act To Lower Drug Prices - Healthcare

Following enactment of the Inflation Reduction Act, which provides for Medicare drug price negotiations, the White House has announced new actions to lower drug costs.

White houseDistrict of columbiaUnited statesVickig nortonBryanc smithCellpro incNational institute of standardsProperty practice groupNational institutes of healthLife sciencesInflation reduction actBayh dole actDole act promotes commercializationSmall business patentProcedures actMarch in rights under

FDA Warning Letters Explained: An Opportunity, Not A Threat - Life Sciences, Biotechnology & Nanotechnology

Receiving a Warning Letter from FDA can seem daunting for any company regulated by FDA, including those offering food, drug, biologic, medical device and cosmetic products.

Coleenw hillPatrickc gallagherRobertm castleLife sciencesWarning letterWarning letter is informalRegulatory proceduresRegulatory procedures manualWarning lettersMedical technologies industryFda warning letters explained an opportunityOta threatCorporate commercial lawCorporate and company lawLife sciencesFood and drugs law